Cargando…

Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming

The biological and clinical heterogeneity of neuroblastoma (NB) demands novel biomarkers and therapeutic targets in order to drive the most appropriate treatment for each patient. Hypoxia is a condition of low-oxygen tension occurring in poorly vascularized tumor tissues. In this study, we aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cangelosi, Davide, Morini, Martina, Zanardi, Nicolò, Sementa, Angela Rita, Muselli, Marco, Conte, Massimo, Garaventa, Alberto, Pfeffer, Ulrich, Bosco, Maria Carla, Varesio, Luigi, Eva, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563184/ https://www.ncbi.nlm.nih.gov/pubmed/32825087 http://dx.doi.org/10.3390/cancers12092343

Ejemplares similares

Artificial neural network classifier predicts neuroblastoma patients’ outcome
por: Cangelosi, Davide, et al.
Publicado: (2016)

Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients
por: Cangelosi, Davide, et al.
Publicado: (2013)

Immunohistochemical analysis of PDK1, PHD3 and HIF-1α expression defines the hypoxic status of neuroblastoma tumors
por: Ognibene, Marzia, et al.
Publicado: (2017)

Connectivity Map Analysis Indicates PI3K/Akt/mTOR Inhibitors as Potential Anti-Hypoxia Drugs in Neuroblastoma
por: Uva, Paolo, et al.
Publicado: (2021)

Use of Attribute Driven Incremental Discretization and Logic Learning Machine to build a prognostic classifier for neuroblastoma patients
por: Cangelosi, Davide, et al.
Publicado: (2014)

PIPE-T: a new Galaxy tool for the analysis of RT-qPCR expression data
por: Zanardi, Nicolò, et al.
Publicado: (2019)

Untargeted LC-HRMS Based-Plasma Metabolomics Reveals 3-O-Methyldopa as a New Biomarker of Poor Prognosis in High-Risk Neuroblastoma
por: Barco, Sebastiano, et al.
Publicado: (2022)

Plasma-Derived Exosome Proteins as Novel Diagnostic and Prognostic Biomarkers in Neuroblastoma Patients
por: Morini, Martina, et al.
Publicado: (2023)

Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study (‖)
por: Morini, Martina, et al.
Publicado: (2019)

Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants
por: Dondero, Alessandra, et al.
Publicado: (2021)

CHL1 gene acts as a tumor suppressor in human neuroblastoma
por: Ognibene, Marzia, et al.
Publicado: (2018)

Favorable prognostic role of tropomodulins in neuroblastoma
por: Bettinsoli, Paola, et al.
Publicado: (2018)

Transcriptome analysis defines myocardium gene signatures in children with ToF and ASD and reveals disease-specific molecular reprogramming in response to surgery with cardiopulmonary bypass
por: Raggi, Federica, et al.
Publicado: (2020)

Nucleolin expression has prognostic value in neuroblastoma patients
por: Cangelosi, Davide, et al.
Publicado: (2022)

Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants
por: Bottino, Cristina, et al.
Publicado: (2022)

Association of telomerase activity with radio- and chemosensitivity of neuroblastomas
por: Wesbuer, Simone, et al.
Publicado: (2010)

Hypoxia Modifies the Transcriptome of Human NK Cells, Modulates Their Immunoregulatory Profile, and Influences NK Cell Subset Migration
por: Parodi, Monica, et al.
Publicado: (2018)

Multiple Genes with Potential Tumor Suppressive Activity Are Present on Chromosome 10q Loss in Neuroblastoma and Are Associated with Poor Prognosis
por: Ognibene, Marzia, et al.
Publicado: (2023)

19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis
por: Lasorsa, Vito Alessandro, et al.
Publicado: (2020)

Detection of GD2-positive cells in bone marrow samples and survival of patients with localised neuroblastoma
por: Corrias, M V, et al.
Publicado: (2008)

MYCN and Metabolic Reprogramming in Neuroblastoma
por: Bansal, Mohit, et al.
Publicado: (2022)

The l(1)-l(2 )regularization framework unmasks the hypoxia signature hidden in the transcriptome of a set of heterogeneous neuroblastoma cell lines
por: Fardin, Paolo, et al.
Publicado: (2009)

Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study
por: Berbegall, Ana P., et al.
Publicado: (2018)

Identification of Multiple Hypoxia Signatures in Neuroblastoma Cell Lines by l(1)-l(2) Regularization and Data Reduction
por: Fardin, Paolo, et al.
Publicado: (2010)

High Grade of Amplification of Six Regions on Chromosome 2p in a Neuroblastoma Patient with Very Poor Outcome: The Putative New Oncogene TSSC1
por: Ognibene, Marzia, et al.
Publicado: (2021)

The epigenetic reprogramming of poorly aggressive melanoma cells by a metastatic microenvironment
por: Seftor, Elisabeth A, et al.
Publicado: (2006)

Hypoxia and hypoxia-inducible factors in neuroblastoma
por: Påhlman, Sven, et al.
Publicado: (2017)

Immunosuppressive Microenvironment in Neuroblastoma
por: Pistoia, Vito, et al.
Publicado: (2013)

A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients
por: Fardin, Paolo, et al.
Publicado: (2010)

Telomeres and Telomerase in the Radiation Response: Implications for Instability, Reprograming, and Carcinogenesis
por: Sishc, Brock J., et al.
Publicado: (2015)

Identification of GALNT14 as a novel neuroblastoma predisposition gene
por: De Mariano, Marilena, et al.
Publicado: (2015)

Deregulation of focal adhesion pathway mediated by miR-659-3p is implicated in bone marrow infiltration of stage M neuroblastoma patients
por: Stigliani, Sara, et al.
Publicado: (2015)

Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome
por: Cornero, Andrea, et al.
Publicado: (2012)

Therapeutic Targeting of ALK in Neuroblastoma: Experience of Italian Precision Medicine in Pediatric Oncology
por: Pastorino, Fabio, et al.
Publicado: (2023)

Artificial Tumor Microenvironments in Neuroblastoma
por: Quinn, Colin H., et al.
Publicado: (2021)

Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
por: Brignole, Chiara, et al.
Publicado: (2021)

Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients
por: Applebaum, Mark A., et al.
Publicado: (2016)

Esthesioneuroblastoma in pediatric and adolescent age. A report from the TREP project in cooperation with the Italian Neuroblastoma and Soft Tissue Sarcoma Committees
por: Bisogno, Gianni, et al.
Publicado: (2012)

Exosomes from Plasma of Neuroblastoma Patients Contain Doublestranded DNA Reflecting the Mutational Status of Parental Tumor Cells
por: Degli Esposti, Chiara, et al.
Publicado: (2021)

Hypoxia in the Initiation and Progression of Neuroblastoma Tumours
por: Huertas-Castaño, Carlos, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_01jpui9vlttl88gtf17u6qmdap